Genetic polymorphisms as a risk factor for dyslipidemia in children.
Dyslipidemia is an important etiological factor for development of cardiovascular disease, which is the leading cause of deaths in adults. Given the growing global epidemic of dyslipidemia, lipoprotein metabolism disorders have become an important health problem not only in adulthood, but have also emerged as an increasingly risk factor in childhood. Although several genome-wide association studies in multiple large population-based cohorts of adults and meta-analyses have identified susceptibility genes or loci, especially in lipid-related traits, it is of great importance to evaluate genetic predisposition at an early age. Recent findings suggest that the identification of polymorphisms in the metabolism of lipids in childhood may help fight subclinical atherosclerosis and its progression to cardiovascular complications in adulthood. Therefore, the aim of this study was to review genetic polymorphisms as risk factors associated with dyslipidemia in children and adolescents.
Department of General Biology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil; Department of Clinical and Toxicological Analyses, Pharmacy School, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
Izabela R
IR
Santos
Department of Clinical and Toxicological Analyses, Pharmacy School, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
Ana Paula
AP
Fernandes
Department of Clinical and Toxicological Analyses, Pharmacy School, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
Marinez O
MO
Sousa
Technical College, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
Cláudia N
CN
Ferreira
Department of General Biology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil; Department of Clinical and Toxicological Analyses, Pharmacy School, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
Karina B
KB
Gomes
Dyslipidemia; cardiovascular risk; childhood; polymorphism